Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety

Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety

Lipid nanoparticle (LNP) formulated messenger RNA-based (LNP-mRNA) vaccines came into the spotlight as the first vaccines against SARS-CoV-2 virus to be applied worldwide. Long-known benefits of mRNA-based technologies consisting of relatively simple and fast engineering of mRNA encoding for antigen...

Full description

Bibliographic Details
Main Author: Irena Vlatkovic
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Biomedicines
Subjects:
lipid nanoparticle
LNP-mRNA
innate immunity
efficacy
safety
cytokines
Online Access:https://www.mdpi.com/2227-9059/9/5/530

Internet

https://www.mdpi.com/2227-9059/9/5/530

Similar Items